Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOSEC™ for Artificial Dermal Wounds in Healthy Males
NCT02284360Phase 1Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2014
- Primary completion
- Jun 2015
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of APOSEC in wound healing (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Adverse Events. Started Oct 2014; status: completed.
02
Drugs
APOSEC
03
Conditions
wound healing
Beyond the preview
Go deeper on NCT02284360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284360.